Lataa...
X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein–Barr virus (EBV). Features include hemophagocytic lymphohistiocytosis (HLH), lymphomas, and dysgammaglobulinemias. Molecular cloning of the causa...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893764/ https://ncbi.nlm.nih.gov/pubmed/29670631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00666 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|